EORTC on the future of cancer research at ECCO 2017
19 Jan 2017
World experts to discuss future methods in cancer research at EORTC ECCO workshop
Our workshop on the Future of Cancer Clinical Research & Therapy will bring together world experts Elizabeth Eisenhauer (Queen’s University, Canada), Stefan Sleijfer (Erasmus University, Netherlands) and Jorge Camarero (European Medicines Agency), to discuss “The regulatory and methodological dimensions of long term efficacy: PFS2 and looking beyond the first progression”.
This discussion will be followed by a session on “Registries and the external validity of clinical trials” with Gemma Gatta (Istituto Nazionale Tumori di Milano), Sabine Siesling (University of Twente, Netherlands) and Harlinde De Schutter (Belgian Cancer Registry).
Poster sessions
In addition, EORTC will be presenting two posters at the European Cancer Congress (ECCO 2017) in Amsterdam (January 27-30, 2017).
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data for Cancer Clinical Trials – SISAQOL consortium (Abstract 1333)
Session 226: Poster in the Spotlight II; Saturday 28.01.2017 – 4:00 PM – 5:00 PM
Location: Poster Area, Hall 1
Author: SISAQOL consortium
Update of the international prognostic classification for first line metastatic germ-cell cancers. An international initiative (Abstract 2197)
Session 255: Poster in the Spotlight IV; Sunday 29.01.2017 – 4:00 PM – 4:50 PM
Location: Poster Area, Hall 1
Author: L. Collette
Oral Presentations
Innovative methodology to optimise translation of trial outcome to real-world patients
Changing Practice Session: The Value of Cancer Registries; Sunday 29.01.2017 – 11:30 AM
Location: Room Zur Hausen
Speaker: L. Liu
Incorporating real-life data into drug development: towards more pragmatic trials
Changing Practice Session: External Validity of Clinical Trials; Monday 30.01.2017 – 10:35 AM
Location: Room Folkman
Speaker: M. Mauer
Related News
New European AI assistant to make patient experiences actionable for care and health systems
12 Nov 2026
First site activated in EORTC STARBURST-1, the research project on muscle-invasive bladder cancer
28 Oct 2026
EORTC at ESMO 2026: New findings and ongoing studies
27 Oct 2026
EORTC research presented at ESMO 2026
22 Oct 2026
EORTC Quality of Life Group at ISOQOL 2026
15 Oct 2026
Pink October 2026: Advancing breast cancer research, together
7 Oct 2026
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
